Back
Avidity Biosciences Quote, Financials, Valuation and Earnings
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.
Sell
28
RNA
Avidity Biosciences
Last Price:
42.16
Seasonality Move:
39.98%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.Avidity Biosciences Price Quote
$42.16
-0.02 (-15.63%)
(Updated: November 16, 2024 at 5:36 AM ET)
Avidity Biosciences Key Stats
Sell
28
Avidity Biosciences (RNA)
is a Sell
Day range:
$41.84 - $50.32
52-week range:
$5.68 - $56.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
486.02
P/B ratio:
3.97%
Volume:
2M
Avg. volume:
983.4K
1-year change:
577.05%
Market cap:
$6B
Revenue:
$9.6M
EPS:
$-2.89
How Much Does Avidity Biosciences Make?
-
How Much Are Avidity Biosciences's Sales Annually?
RNA Revenues are $9.6M -
How Much Profit Does Avidity Biosciences's Make A Year?
RNA net income is -$212.2M
Is Avidity Biosciences Growing As A Company?
-
What Is Avidity Biosciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.17% -
What Is Avidity Biosciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Avidity Biosciences Stock Price Performance
-
Did Avidity Biosciences Stock Go Up Last Month?
Avidity Biosciences share price went down by -9.68% last month -
Did RNA's Share Price Rise Over The Last Year?
RNA share price rose by 577.05% over the past 1 year
What Is Avidity Biosciences 52-Week High & Low?
-
What Is Avidity Biosciences’s 52-Week High Share Price?
Avidity Biosciences has traded as high as $56.00 over the past 52 weeks -
What Is Avidity Biosciences’s 52-Week Low Share Price?
Avidity Biosciences has traded as low as $5.68 over the past 52 weeks
Avidity Biosciences Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Avidity Biosciences?
-
How Much Debt Does Avidity Biosciences Have?
Total long term debt quarterly is $0 -
How Much Cash Does Avidity Biosciences Have?
Cash and short term investments quarterly total is $1.6B -
What Is Avidity Biosciences’s Book Value Per Share?
Book value per share is 12.64
Is Avidity Biosciences Cash Flow Positive?
-
What Is RNA Cash Flow From Operations?
Cash flow from operations (TTM) is -$184.5M -
What Is Avidity Biosciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.2B -
What Is Avidity Biosciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$739M
Avidity Biosciences Return On Invested Capital
-
Is Management Doing A Good Job?
RNA return on invested capital is -30.66% -
What Is Avidity Biosciences Return On Assets?
ROA measures how assets are converting to revenues and is -27.28% -
What Is RNA Return On Equity?
ROE is a measure of profitability and is -30.66%
Avidity Biosciences Earnings Date & Stock Price
-
What Is Avidity Biosciences's Stock Price Today?
A single share of RNA can be purchased today for 42.18 -
What Is Avidity Biosciences’s Stock Symbol?
Avidity Biosciences trades on the nasdaq under the ticker symbol: RNA -
When Is Avidity Biosciences’s Next Earnings Date?
The next quarterly earnings date for Avidity Biosciences is scheduled on February 28, 2025 -
When Is RNA's next ex-dividend date?
Avidity Biosciences's next ex-dividend date is November 16, 2024 -
How To Buy Avidity Biosciences Stock?
You can buy Avidity Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Avidity Biosciences Competitors
-
Who Are Avidity Biosciences's Competitors?
Below is a list of companies who compete with Avidity Biosciences or are related in some way:
Avidity Biosciences Dividend Yield
-
What Is RNA Dividend Yield?
Avidity Biosciences’s dividend yield currently is 0% -
What Is Avidity Biosciences’s Payout Ratio?
Avidity Biosciences’s payout ratio is 0% -
When Did Avidity Biosciences Last Pay A Dividend?
The latest dividend pay date is November 16, 2024 -
What Is Avidity Biosciences’s Dividend Per Share?
Avidity Biosciences pays a dividend of $0.00 per share
Avidity Biosciences Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 9.52% |
| Revenue: | -17.1% | -48.99% |
Analyst Recommendations
| Buy Recommendations: | 8 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 67.91 |
| Upside from Last Price: | 61% |